跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVETIRACETAM INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LEVETIRACETAM INJECTION USP
Authorized
STANDARD
LEVETIRACETAM INJECTION USP
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b8230b085782da93
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
b8230b085782da93
Drug Approval Canada Name
LEVETIRACETAM INJECTION USP
Product Name
LEVETIRACETAM INJECTION USP
Status
Marketed
Status Date
2022-08-05
Original Market Date
2022-08-05
Din
02527375
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
28:12.92
Atc Original
N03AX14 LEVETIRACETAM
Atc Name
n 03 ax 14
Aig Number
0148843005
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
LEVETIRACETAM
100 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b8230b085782da93
Type
Standard
Back to Health Canada Approvals